Year |
Citation |
Score |
2016 |
Arteaga-Marrero N, Rygh CB, Mainou-Gomez JF, Adamsen TC, Lutay N, Reed RK, Olsen DR. Erratum to: Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US. Journal of Translational Medicine. 14: 59. PMID 26911196 DOI: 10.1186/s12967-016-0813-0 |
0.464 |
|
2015 |
Arteaga-Marrero N, Brekke Rygh C, Mainou-Gomez JF, Adamsen TC, Lutay N, Reed RK, Olsen DR. Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US. Journal of Translational Medicine. 13: 383. PMID 26682742 DOI: 10.1186/s12967-015-0708-5 |
0.503 |
|
2009 |
Swanson KR, Chakraborty G, Wang CH, Rockne R, Harpold HL, Muzi M, Adamsen TC, Krohn KA, Spence AM. Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomas. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 36-44. PMID 19091885 DOI: 10.2967/Jnumed.108.055467 |
0.421 |
|
2008 |
Spence AM, Muzi M, Swanson KR, O'Sullivan F, Rockhill JK, Rajendran JG, Adamsen TC, Link JM, Swanson PE, Yagle KJ, Rostomily RC, Silbergeld DL, Krohn KA. Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 2623-30. PMID 18451225 DOI: 10.1158/1078-0432.Ccr-07-4995 |
0.413 |
|
2004 |
Burrows RC, Freeman SD, Charlop AW, Wiseman RW, Adamsen TC, Krohn KA, Spence AM. [18F]-2-fluoro-2-deoxyglucose transport kinetics as a function of extracellular glucose concentration in malignant glioma, fibroblast and macrophage cells in vitro. Nuclear Medicine and Biology. 31: 1-9. PMID 14741565 DOI: 10.1016/S0969-8051(02)00449-3 |
0.365 |
|
Show low-probability matches. |